XAGE_OUT_1 [2025-04-03 06:37:34 -0400] 2263 Bytes | 604 tokens | Cum: 604 tkns (7.55% of 8k)
==========================================================================

Listen up, partner—it's 6:37:33 AM on Thu Apr 03, 2025 -0400, and I’m revved up about Longevity Health (XAGE), climbing from 0.1319 to 0.156. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

--- COMPANY PROFILE ---
Company: Longevity Health (XAGE)
IPO: IPO date unknown
Shares Outstanding: 30,120,000
Industry: SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS
Exchange: XNAS

Here's the first list of news for Longevity Health:

C1 - Jan-16-25 08:00AM - Carmell Announces Closing of Elevai Skincare Acquisition
C2 - Jan-03-25 08:00AM - Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
C3 - Jan-02-25 08:00AM - Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
C4 - Dec-24-24 08:30AM - Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
C5 - Sep-05-24 08:30AM - Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community
C6 - Jul-29-24 08:30AM - Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
C7 - May-16-24 08:54AM - CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023
C8 - Apr-11-24 04:30PM - Carmell Announces Successful Closing of $3.0 Million Private Placement

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Longevity Health (XAGE)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

XAGE_OUT_3 [2025-04-03 06:37:39 -0400] 1130 Bytes | 330 tokens | Cum: 936 tkns (11.70% of 8k)
==========================================================================

Showing C1 (chunk 1 of 8): C1:
**Carmell Announces Closing of Elevai Skincare Acquisition**
Date: Jan-16-25 08:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/01/16/3010757/0/en/Carmell-Announces-Closing-of-Elevai-Skincare-Acquisition.html

January 16, 2025 08:00 ET| Source:Carmell CorporationCarmell Corporation

PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced the closing of the previously announced acquisition of the skin and hair care business of Elevai Skincare, Inc. (“Elevai”), a leader in physician dispensed exosome skin and hair care products, pursuant to a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) (“PMGC”) and Elevai, its wholly owned subsidiary (the “Acquisition”).

At the clos

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XAGE_OUT_5 [2025-04-03 06:37:40 -0400] 1013 Bytes | 309 tokens | Cum: 1325 tkns (16.56% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-27T17:05:46Z - 12 Health Care Stocks Moving In Thursday's Intraday Session - AquaBounty Techs (NASDAQ:AQB), CervoMe...
A2 - 2025-03-19T21:06:24Z - 12 Health Care Stocks Moving In Wednesday's After-Market Session - Akebia Therapeutics (NASDAQ:AKBA)...
A3 - 2025-03-13T21:17:00Z - 12 Health Care Stocks Moving In Thursday's After-Market Session - Aspira Womens Health (NASDAQ:AWH),...
A4 - 2025-03-11T00:54:24Z - CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO - South Africa Today...
A5 - 2025-03-10T12:49:12Z - CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY - C...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

XAGE_OUT_7 [2025-04-03 06:37:40 -0400] 1098 Bytes | 340 tokens | Cum: 1667 tkns (20.84% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Thursday's Intraday Session - AquaBounty Techs (NASDAQ:AQB), CervoMed (NASDAQ:CRVO)**Date: 2025-03-27Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44520201/12-health-care-stocks-moving-in-thursdays-intraday-sessionGainers 23andMe Holding ME stock increased by 79.1% to $0.95 during Thursday's regular session. The market value of their outstanding shares is at $25.4 million. Nkarta NKTX stock increased by 55.41% to $2.13. The company's market cap stands at $150.2 million. As per the news, the Q4 earnings report came out yesterday. Regulus Therapeutics RGLS stock moved upwards by 53.87% to $1.99. The market value of their outstanding shares is at $131.4 million. Soleno Therapeutics SLNO shares increased by 43.33% to $70.19. The company's market cap stands at $3.0 billion. Cerv

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XAGE_OUT_9 [2025-04-03 06:37:41 -0400] 267 Bytes | 67 tokens | Cum: 1736 tkns (21.70% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

XAGE_OUT_11 [2025-04-03 06:37:43 -0400] 253 Bytes | 85 tokens | Cum: 1823 tkns (22.79% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
Document B1 not found. Only 0 articles available.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XAGE_OUT_13 [2025-04-03 06:37:44 -0400] 1079 Bytes | 294 tokens | Cum: 2149 tkns (26.86% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-31 10-K Item 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the accompanying CONS financial statements and the...

S2 - 2025-03-10 8-K Item 9.01 Fin Stmnts and Exhibits.

(d) Exhibits

Exhibit

Description

3.1

Certificate of Amendment to Third Amended and Restated Certificate of Incorporation, effective March 5, 2025

3.2

Amended and Restated Bylaws

99.1

Press release, dated as of March 1...

S3 - 2025-01-16 8-K Item 9.01 Fin Stmnts and Exhibits.

(a) Fin statements of business acquired.

The financial statements required by Item 9.01(a) of Form 8-K will be filed by an amendment to this Curr Report on Form 8-K no later than 71 calendar days after the date this Curren...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

XAGE_OUT_15 [2025-04-03 06:37:45 -0400] 1098 Bytes | 240 tokens | Cum: 2391 tkns (29.89% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
Item 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the accompanying consolidated financial statements and the related notes contained in Part II, Item 8 of this Annual Report. Certain information in this discussion and analysis or as set forth elsewhere in this Annual Report contains forward-looking statements that involve numerous risks and uncertainties, including, but not limited to, those described under the section entitled Forward-Looking Statements in Part I, Item 1. Business in this Annual Report and under Part I, Item 1A. Risk Factors in this Annual Report. We assume no obligation to update any of these forward-looking statements. Actual results may differ materially from those contained in any forward-looki

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XAGE_OUT_17 [2025-04-03 06:37:46 -0400] 1098 Bytes | 250 tokens | Cum: 2643 tkns (33.04% of 8k)
==========================================================================

Showing S1 (chunk 2 of 6): ng statements.

Overview

We are focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. Our products are aimed to help people look and feel their best at any age. We currently have two cosmetic product lines, Carmell Secretome TM and Elevai Exosomes TM , that support skin and hair health. All of our cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. Our product pipeline also includes innovative regenerative bone and tissue healing products on which further research and development has been paused.

Recent Developments

Private Placement

On January 2, 2025, we closed the 2025 Private Placement, whereby we received gross proceeds of $1,851,849 for the sale of 8,065,210 shares of Common Stock and warrants to purchas

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XAGE_OUT_19 [2025-04-03 06:37:57 -0400] 3193 Bytes | 819 tokens | Cum: 3464 tkns (43.30% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+-------------------+
| Volume: 541,409 | Perf Month: -33.05% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+--------------------+-----------------------+------------------------+-------------------+
| Avg Volume: 1.64M | Perf Quarter: -54.39% | Short Float: 2.57% | ROE: - |
+--------------------+-----------------------+------------------------+-------------------+
| Rel Volume: 0.08 | Index: - | Short Ratio: 0.36 | ROI: - |
+--------------------+-----------------------+------------------------+-------------------+
| RSI (14): 32.04 | Market Cap: 3.97M | Short Interest: 0.58M | Sales Surprise: - |
+--------------------+-----------------------+------------------------+-------------------+
| ATR (14): 0.04 | Shs Outstand: 30.12M | Beta: 0.76 | EPS Surprise: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA20: -32.86% | Shs Float: 22.68M | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA50: -50.21% | Inst Own: 7.77% | Sales past 5Y: 0.00% | Earnings: - |
+--------------------+-----------------------+------------------------+-------------------+
| SMA200: -76.67% | Insider Own: 24.70% | Employees: 15 | |
+--------------------+-----------------------+------------------------+-------------------+
| Perf Week: -22.41% | Insider Trans: 0.00% | Debt/Eq: - | |
+--------------------+-----------------------+------------------------+-------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.1319
Average Volume: 3960744.39
30-Day High: 0.32
30-Day Low: 0.123
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

XAGE_OUT_21 [2025-04-03 06:38:00 -0400] 676 Bytes | 167 tokens | Cum: 3878 tkns (48.48% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

XAGE_IN_23 [2025-04-03 06:38:00 -0400] 126 Bytes | 29 tokens | Cum: 3934 tkns (49.18% of 8k)
==========================================================================

====================================
[2025-04-03 06:38:00] # Analysis Completed
Elapsed Time: 27.17 seconds